Press Releases from Biogenum (1 total)
Biogenum Announces Favorable Safety Profile for Tau NonTangles™ in a Phase 1/2 …
Tau NonTangles™ - small molecule for Alzheimer’s disease treatment is associated with clinical signs consistent with improvements in motor symptoms and dyskinesias…
Go To Page:
